Judith Fran Marks - 03 Feb 2026 Form 4 Insider Report for Otis Worldwide Corp (OTIS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Feb 2026, 19:49:59 UTC
Prior SEC filing
13 Jun 2025
Next SEC filing
10 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Susan Grady, Attorney-in-Fact

Key filing fact

Judith Fran Marks filed Form 4 for Otis Worldwide Corp (OTIS) on 05 Feb 2026.

Key facts

  • This page summarizes Judith Fran Marks's Form 4 filing for Otis Worldwide Corp (OTIS).
  • 11 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 05 Feb 2026, 19:49.

Change

  • Previous filing in this sequence was filed on 13 Jun 2025.
  • Current net transaction value: -$11,090,025.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001665490 Primary reporting owner

Marks Judith Fran

Relationship
Chair, CEO and President, Director
Address
1 CARRIER PLACE, FARMINGTON
Signature
Susan Grady, Attorney-in-Fact
Signature date
05 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OTIS transaction

Common Stock

Award

Transaction value
Shares
+58,169
Change %
+26%
Price
Shares after
279,781
Date
03 Feb 2026
Ownership
Direct
Footnotes
F5
OTIS transaction

Common Stock

Tax liability

Transaction value
$1,052,283
Shares
-12,073
Change %
-4.3%
Price
$87.16
Shares after
267,708
Date
03 Feb 2026
Ownership
Direct
OTIS transaction

Common Stock

Options Exercise

Transaction value
Shares
+18,425
Change %
+6.9%
Price
Shares after
286,133
Date
04 Feb 2026
Ownership
Direct
Footnotes
F1
OTIS transaction

Common Stock

Tax liability

Transaction value
$748,354
Shares
-8,281
Change %
-2.9%
Price
$90.37
Shares after
277,852
Date
04 Feb 2026
Ownership
Direct
OTIS transaction

Common Stock

Sale

Transaction value
$4,190,057
Shares
-46,780
Change %
-17%
Price
$89.57
Shares after
231,072
Date
04 Feb 2026
Ownership
Direct
Footnotes
F6
OTIS transaction

Common Stock

Options Exercise

Transaction value
$12,259,792
Shares
+191,799
Change %
+83%
Price
$63.92
Shares after
422,871
Date
04 Feb 2026
Ownership
Direct
Footnotes
F4
OTIS transaction

Common Stock

Disposed to Issuer

Transaction value
$12,259,772
Shares
-135,692
Change %
-32%
Price
$90.35
Shares after
287,179
Date
04 Feb 2026
Ownership
Direct
OTIS transaction

Common Stock

Sale

Transaction value
$5,099,352
Shares
-56,107
Change %
-20%
Price
$90.89
Shares after
231,072
Date
05 Feb 2026
Ownership
Direct
Footnotes
F7, F8
OTIS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
23,000
Date
03 Feb 2026
Ownership
by 2025 GRAT
Footnotes
F9

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OTIS transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+59,305
Change %
Price
$0.000000
Shares after
59,305
Date
03 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
59,305
Exercise price
Footnotes
F1, F2
OTIS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-18,425
Change %
-33%
Price
$0.000000
Shares after
36,862
Date
04 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
18,425
Exercise price
Footnotes
F1, F3
OTIS transaction Derivative

Stock Appreciation Rights

Options Exercise

Transaction value
$0
Shares
-191,799
Change %
-100%
Price
$0.000000
Shares after
0
Date
04 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
191,799
Exercise price
$63.92
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 9 footnotes

Footnote F1

Restricted stock units (RSUs) convert into common stock on a one-for-one basis. RSUs include the right to receive dividend equivalents that are credited as additional RSUs.

Footnote F2

RSUs vest in three substantially equal annual installments beginning on the first anniversary of the Transaction Date.

Footnote F3

On February 4, 2025, the reporting person was granted RSUs vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. The first installment vested on the Transaction Date.

Footnote F4

This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2025.

Footnote F5

The acquisition of Otis common stock represents the vesting of performance share units (PSUs) previously awarded on February 7, 2023. Each PSU has a value equal to one share of Otis common stock. These PSUs vested on the Transaction Date upon the achievement of the 3-year cycle preestablished performance targets. The performance criteria were certified to be achieved at the 82% level. The reporting person previously elected to defer 50% of this award under the LTIP PSU Deferral Plan upon vesting. Any vested shares that are deferred under this plan are credited as DSUs and will be settled in stock. The DSUs will be paid out in an equal number of shares of Otis common stock in accordance with the reporting person's previous elections. DSUs accrue dividend equivalents.

Footnote F6

This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2025. The shares sold in multiple trades at prices ranging from $87.73 to $90.45. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide the registrant, any security holder of the registrant, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The number of shares sold includes the shares received by the reporting person upon the vesting of the PSUs previously awarded on February 7, 2023 after giving effect to the tax withholdings and the 50% PSU deferral election.

Footnote F7

This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2025. The shares sold in multiple trades at prices ranging from $89.755 to $91.495. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide the registrant, any security holder of the registrant, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F8

Includes (i) 12,800 shares previously held through the 2023 grantor retained annuity trust (GRAT) which were transferred to the reporting person on August 25, 2025 and are now owned directly and (ii) 1,658 dividend equivalents issued on DSU's under the LTIP PSU Deferral Plan since March 2025.

Footnote F9

The reporting person established a GRAT on September 5, 2025 and contributed 23,000 shares of the Issuer's common stock to it on September 10, 2025. The reporting person is the sole trustee and annuitant of the GRAT, which is scheduled to expire in accordance with its terms on September 10, 2027.

SEC remarks

Exhibit List: Exhibit 24 - Power of Attorney. This form includes transactions effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2025. The plan will terminate on March 1, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .